Insights
![](https://bereskinparr.com/wp-content/uploads/2023/05/InsightsNews_Insights_Header_1100x515.jpg)
Updating results
Showing results 1 - 24 of 25 Results per page:
No results found.
Explore our Insights
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_1676651968-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_141657622-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/04/BP_Insights_Events_Thumb09_660x880-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_18136510-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/04/BP_Insights_Events_Thumb10_660x880-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/04/BP_Insights_Events_Thumb05_660x880-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_314196572-365x487.jpg)
May 4, 2021
Federal Court of Appeal Affirms Minister’s Decision that CSP Eligibility Requires Claim for Active Ingredients and Excludes Formulations Claims
›![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_2231570535-365x487.jpg)
March 24, 2021
Nearly 400-Year-Old English Statute of Monopolies Not Applicable to Damage Claim Under Canada’s Patented Drug Regime
›![](https://bereskinparr.com/wp-content/uploads/2023/04/BP_Insights_Events_Thumb06_660x880-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_51674026-365x487.jpg)
February 22, 2021
Federal Court Dismisses Limitation Period Defence in Patent Infringement Action under Section 8.2 of the PM(NOC) Regulations
›![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_739496338-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/04/BP_Insights_Events_Thumb09_660x880-365x487.jpg)
Subscribe to our newsletter
![](https://bereskinparr.com/wp-content/uploads/2023/04/BP_Insights_Events_Thumb02_660x880-365x487.jpg)
December 9, 2020
Federal Court of Appeal Clarifies that a “Direct Impact” is Required to Obtain Leave to Appeal Interlocutory Orders in PM(NOC) Actions
›![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_443554123-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_1676651968-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/04/BP_Insights_Events_Thumb03_660x880-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_417594604-365x487.jpg)
August 1, 2019
Balancing Efficiency and Compressed Timelines: Two Years into the Amended Patented Medicines (Notice of Compliance) Regulations
›![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_1572203692-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_158577809-365x487.jpg)
August 23, 2018
Advantages Making the Federal Court of Canada an Increasingly Desirable Forum for Intellectual Property Disputes
›![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_191836994-365x487.jpg)
August 22, 2018
HERCEPTIN Patents Survive Preliminary Non-Infringement Challenge in the First Motion Under Section 6.08 of the Patented Medicines (Notice of Compliance) Regulations
›![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_314196572-365x487.jpg)
August 10, 2018
Did You Unintentionally Just Settle? A Cautionary Reminder to be Objectively Clear in Your Negotiations
›![](https://bereskinparr.com/wp-content/uploads/2023/04/BP_Insights_Events_Thumb08_660x880-365x487.jpg)
June 12, 2018
Market Share Used to Establish Sales a Patentee “Could and Would” Have Made but for Infringement: Grenke v DNOW Canada ULC
›![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_324734822-365x487.jpg)
April 4, 2018
Motion to Vary Confidentiality Restrictions in PM(NOC) Case Can Only be Brought After Action is Commenced
›![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_378224113-365x487.jpg)
March 29, 2018
Collett v. Northland – “Retribution and Denunciation” for Egregious Infringement that Raises Questions On the Scope of Copyright and Moral Rights
›
Loading...
Showing results 1 - 24 of 25 Results per page:
No results found.